米国市場銘柄情報

KBR KBR

銘柄追加

68.000
+1.210+1.81%

終値 05/06 16:00 ET

69.640
+1.640+2.41%

市場後 19:59 ET

91.31億時価総額-37158直近PER

KBRに関するコメント

ログインコメントを投稿

Moomoo AI

03/11 19:23

KBR's revenue growth could be seen as a positive sign, despite potential sacrifice of current earnings per share. Future earnings are crucial for shareholders. Despite slower share price gains, the business may continue to perform well.

Those Who Invested in KBR (NYSE:KBR) Five Years Ago Are up 238%

Moomoo AI

2023/12/27 18:29

Given the upward trend and increased efficiency in KBR's return on capital employed, it appears to show promise. Considering the outstanding shareholder returns over the last five years, it's advisable for investors to explore if these trends will continue.

KBR (NYSE:KBR) Shareholders Will Want The ROCE Trajectory To Continue

Moomoo AI

2023/10/31 23:29

Sizable insider selling at KBR creating investor caution. Lack of insider buying combined with substantial selling seen as red flag. 1.0% insider ownership doesn't fully dispel concerns.

KBR Insiders Sold US$2.5m Of Shares Suggesting Hesitancy

Mooers Radar

2023/05/02 06:19

コラムUS Top Gap Ups and Downs on 5/1: JPM, UBER, WFC, F and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $ON セミコンダクタ(ON.US)$ - up 3.0%
2. $JPモルガンチェース(JPM.US)$ - up 1.8%
3. $ウーバーテクノロジーズ(UBER.US)$ - up 1.6%
4. $KBR(KBR.US)$ - up 0.8%
5. $ウェルズファーゴ(WFC.US)$ - up 0.7%
6. $ジェームス・ハーディ・インダストリーズ(JHX.US)$ - up 0.5%
7. $セルシウスホールディングス(CELH.US)$ - up 0.5%
8....

Moomoo Breakfast US

2022/05/19 20:15

コラムToday's pre-market stock movers: GOOS, TSLA, KSS, UAA and more

Gainers:
• $ロケットファーマシューティカルズ(RCKT.US)$ +10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy)
• $カナダ・グース(GOOS.US)$ +9.4% (the company reported an unexpected profit as well as better-than-expected revenue)
• $シガテクノロジーズ(SIGA.US)$ +6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...